1
0
0
(1 - 12 von 14
)
Epidemiology of urinary tract infections in type 2 diabetes ...Sid Italia
www.siditalia.it
von T Wilke · · Zitiert von: 90 — Thomas Wilke a,⁎, Bjoern Boettger a, Bjoern Berg a, Antje Groth a, Sabrina Mueller a, Marc Botteman b,. Shengsheng Yu c, Andreas Fuchs d, Ulf ... von T Wilke · · Zitiert von: 90 — Thomas Wilke a,⁎, Bjoern Boettger a, Bjoern Berg a, Antje Groth a, Sabrina Mueller a, Marc Botteman b,. Shengsheng Yu c, Andreas Fuchs d, Ulf ...
Epidemiology of urinary tract infections in type 2 diabetes ...ScienceDirect.com
www.sciencedirect.com
von T Wilke · · Zitiert von: 90 — Author links open overlay panel. Thomas Wilke a , Bjoern Boettger a , Bjoern Berg a , Antje Groth a , Sabrina Mueller a , Marc Botteman b , Shengsheng Yu c von T Wilke · · Zitiert von: 90 — Author links open overlay panel. Thomas Wilke a , Bjoern Boettger a , Bjoern Berg a , Antje Groth a , Sabrina Mueller a , Marc Botteman b , Shengsheng Yu c
ScienceDirect.com
www.sciencedirect.com
Thomas Wilke, Bjoern Boettger, Bjoern Berg, Antje Groth, ... Ulf Maywald. Pages : View PDF. Article preview. select article Urine matrix ...
Thrombosis Research | Vol 134, Issue 5, Pages
www.sciencedirect.com
Björn Böttger, Martin Wehling, Rupert M. Bauersachs, Steffen Amann, ... Thomas Wilke. Pages : Download PDF. Article preview. › issue
Preferences for anticoagulation therapy in atrial fibrillationNational Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von B Böttger · · Zitiert von: 54 — Authors. Björn Böttger , Inga-Marion Thate-Waschke , Rupert Bauersachs , Thomas Kohlmann , Thomas Wilke. Affiliations. 1 Institut für ... von B Böttger · · Zitiert von: 54 — Authors. Björn Böttger , Inga-Marion Thate-Waschke , Rupert Bauersachs , Thomas Kohlmann , Thomas Wilke. Affiliations. 1 Institut für ...
Prevalence of renal insufficiency in hospitalised patients ...ClinicalKey
www.clinicalkey.com
Björn Böttger ·, Martin Wehling ·, Rupert M. Bauersachs ·, Steffen Amann ·, Andreas Schuchert ·, Christian Reinhold ·, Philipp Kümpers · and Thomas Wilke. Björn Böttger ·, Martin Wehling ·, Rupert M. Bauersachs ·, Steffen Amann ·, Andreas Schuchert ·, Christian Reinhold ·, Philipp Kümpers · and Thomas Wilke.
Prophylaxis of venous thromboembolism in patients with ...OUCI
ouci.dntb.gov.ua
Bjoern Boettger, Martin Wehling, Rupert M. Bauersachs, Steffen Amann, Thomas Wilke. https://doi.org s z · , Journal of Public ... Bjoern Boettger, Martin Wehling, Rupert M. Bauersachs, Steffen Amann, Thomas Wilke. https://doi.org s z · , Journal of Public ...
Epidemiology of urinary tract infections in type 2 diabetes mellitus...
www.infona.pl
von T Wilke · · Zitiert von: 58 — Thomas Wilke, Bjoern Boettger, Bjoern Berg, Antje Groth, Sabrina Mueller, Marc Botteman, Shengsheng Yu, Andreas Fuchs, Ulf Maywald. › resource
Altmetric – Healthcare Burden and Costs Associated with Urinary Tract...
karger.altmetric.com
Thomas Wilke, Björn Böttger, Björn Berg, Antje Groth, Marc Botteman, Shengsheng Yu, Andreas Fuchs, Ulf Maywald. Abstract. We examined ...
OUCIhttps://ouci.dntb.gov.ua › worksPatient perspective on the management of atrial fibrillation in ...
ouci.dntb.gov.ua
Björn Böttger, Inga-Marion Thate-Waschke, Rupert Bauersachs, Thomas Kohlmann, Thomas Wilke. https://doi.org s x · , Journal of ...
OUCIhttps://ouci.dntb.gov.ua › worksPreferences for anticoagulation therapy in atrial fibrillation
ouci.dntb.gov.ua
Björn Böttger, Inga-Marion Thate-Waschke, Rupert Bauersachs, Thomas Kohlmann, Thomas Wilke. Funder Bayer Vital GmbH, Germany. List of references. Ryder KM ...
Alle Infos zum Namen "Björn Böttger"
sortiert nach Relevanz / Datum